menu
    • menu
    [{"orgOrder":0,"company":"Tessenderlo Chemie NV","sponsor":"Tessenderlo Chemie NV","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Protein","year":"2023","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Neurology","graph2":"Undisclosed","graph3":"Tessenderlo Chemie NV","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Tessenderlo Chemie NV \/ Tessenderlo Chemie NV","highestDevelopmentStatusID":"1","companyTruncated":"Tessenderlo Chemie NV \/ Tessenderlo Chemie NV"},{"orgOrder":0,"company":"Tessenderlo Chemie NV","sponsor":"Tessenderlo Chemie NV","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Solugel","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Tessenderlo Chemie NV","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Gel","sponsorNew":"Tessenderlo Chemie NV \/ Tessenderlo Chemie NV","highestDevelopmentStatusID":"1","companyTruncated":"Tessenderlo Chemie NV \/ Tessenderlo Chemie NV"}]

    Find Clinical Drug Pipeline Developments & Deals by Tessenderlo Chemie NV

    Menu

    Tessenderlo Chemie NV

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Tessenderlo Chemie NV

                            Belgium arrow
                            AAPS
                            Not Confirmed

                            Tessenderlo Chemie NV

                            Belgium arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Solugel

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Undisclosed

                            Recipient : University of Arkansas

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound He...

                            Details : Solugel is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Osteoarthritis, Knee.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            April 21, 2023

                            Lead Product(s) : Solugel

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Undisclosed

                            Recipient : University of Arkansas

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Tessenderlo Chemie NV

                            Belgium arrow
                            AAPS
                            Not Confirmed

                            Tessenderlo Chemie NV

                            Belgium arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Collagen

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Recipient : Florida State University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Collagen Peptide Supplementation and Lifelong Athletes

                            Details : Collagen is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Pain.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            March 02, 2023

                            Lead Product(s) : Collagen

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Recipient : Florida State University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth